LSD Just Passed Its Biggest Test Yet for Treating Depression
Definium’s LSD-based depression treatment aces Phase 3 trial, sending shares soaring and redefining mental health research
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The company’s stock surged following the news, reflecting investor confidence in the breakthrough. Regulatory and market reactions remain the focus, though specifics on long-term safety or approval timelines are not yet detailed.
Next steps hinge on regulatory submissions and potential FDA review, which could accelerate or delay market entry. If approved, the drug may reshape depression treatment paradigms, though broader adoption will depend on manufacturing scalability and public acceptance of psychedelic therapies.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (57% supported) Updated 1d ago.
Quick answers
What company developed the LSD-based antidepressant?
Definium Therapeutics (DFTX) developed the LSD-based depression treatment that passed Phase 3 trials.
Which outlets are covering this story?
Coverage includes *Reuters*, *Yahoo Finance*, *Fierce Biotech*, *Psychedelic Alpha*, and *Gizmodo*.
Has the drug been approved yet?
No—this is Phase 3 trial data; approval would require regulatory review, likely by the FDA or equivalent body.
Coverage (8)
- Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026 Business Wire · 1d ago
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder Business Wire · 1d ago
- Definium LSD therapy helped patients with major depression in late-stage trial statnews.com · 1d ago
- Breaking: Definium Lands Positive Phase 3, LSD Candidate Shows Strong Antidepressant Effect Psychedelic Alpha · 1d ago
- Definium Therapeutics (DFTX) Hits New High on Impressive Drug Candidate Trial Yahoo Finance · 1d ago
- Definium’s LSD formula produces ‘best data ever seen’ in a pivotal depression trial, CEO says Fierce Biotech · 1d ago
- Definium's LSD-based depression pill delivers strong late-stage results, shares surge Reuters · 1d ago
- LSD Just Passed Its Biggest Test Yet for Treating Depression Gizmodo · 1d ago
Topics
Related trends
FedEx Revenue Beats But Stock Undercuts A Key Level
Nvidia liquid cooling design claims 100% reduction in water use
THE WENDY'S COMPANY NAMES STEVE CIRULIS CHIEF FINANCIAL OFFICER AND CHIEF STRATEGY OFFICER
The Wendy’s Company has appointed industry veteran Steve Cirulis as its new Chief Financial Officer and Chief Strategy Officer.
Mastercard (MA) Faces Fresh EU Pressure As Digital Euro Plans Advance
Alphabet Stock (GOOGL) Joins Dow Jones as Mag 7 Takeover Nears Completion
Nvidia pours cold water on AI fears
Nvidia claims to have cracked AI’s cooling crisis—without relying on new chips